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Abstract
We have previously shown that mesenchymal stem cells (MSC) improve function upon integration in ischemic myocardium.
We examined whether specific cytokines and growth factors produced by MSCs are able to affect angiogenesis, cellular
migration and apoptosis. Conditioned media (CM) was prepared by culturing MSC for 48 hours. CM displayed significantly
elevated levels of VEGF, Monocyte Chemoattractant Protein-1 (MCP-1), macrophage inflammatory protein-1a (MIP-1a), MIP-
1b and monokine induced by IFN-c (MIG) compared to control media. MSC contained RNA for these factors as detected by
RT-PCR. CM was able to induce angiogenesis in canine vascular endothelial cells. MCP-1 and MIP-1a increased cell migration
of MSC while VEGF reduced it. H9c2 cells treated with CM under hypoxic conditions for 24 hours displayed a 16% reduction
in caspase-3 activity compared to controls. PI 3-kinase c inhibitor had no effect on controls but reversed the effect of CM on
caspase-3 activity. MCP-1 alone mimicked the protective effect of CM while the PI 3-Kc inhibitor did not reverse the effect of
MCP-1. CM reduced phospho-BAD (Ser112) and phospho-Akt (Ser473) while increasing phospho-Akt (Thr308). MCP-1
reduced the level of phospho-Akt (Ser473) while having no effect on the other two; the PI 3-Kc inhibitor did not alter the
MCP-1 effect. ERK 1/2 phosphorylation was reduced in CM treated H9c2 cells, and inhibition of ERK 1/2 reduced the
phosphorylation of Akt (Ser473), Akt (Thr308) and Bad (Ser112). In conclusion, MSC synthesize and secrete multiple
paracrine factors that are able to affect MSC migration, promote angiogenesis and reduce apoptosis. While both MCP-1 and
PI3-kinase are involved in the protective effect, they are independent of each other. It is likely that multiple pro-survival
factors in addition to MCP-1 are secreted by MSC which act on divergent intracellular signaling pathways.
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Introduction
Ischemic injury to the heart results in scarring of the
myocardium and significant reduction in function. Numerous
studies have been performed to determine the potential for
exogenous stem cells to reverse the deleterious effects of
myocardial infarction, and the results have all shown an
improvement in cardiac function. However, the mechanism
leading to this improvement is unclear, since not all investigators
have seen a reduction in scarring due to cardiomyocyte
differentiation of stem cells.
We have recently shown that intravenously injected mesenchy-
mal stem cells (MSC) are able to prevent the loss of function that
occurs in mouse hearts following permanent coronary artery
occlusion [1]. This beneficial effect is seen without any reduction
in scar tissue and ventricular dilatation or significant levels of stem
cell differentiation into cardiomyocytes. It may be that stem cells
are able to contribute to functional improvements by mechanisms
such as increased blood vessel formation or a reduction in cell
death [2]. In order to test this hypothesis we monitored the
production of cytokines by MSC. We then determined the effect of
MSC paracrine factors on cellular migration of MSC, angiogenesis
by canine vascular endothelial cells and apoptosis in H9c2
myoblasts.
Materials and Methods
Mice were housed in the Biological Resources Laboratory at
UIC (AAALAC accredited) and maintained in accordance with
the Guide for the Care and Use of Laboratory Animals (National Research
Council, revised 1996). Experimental protocols were approved by
the Institutional Animal Care and Use Committee at UIC.
Mesenchymal Stem Cell (MSC) Culture
Mesenchymal stem cells (MSC) were isolated from FVB.Cg-
Tg(GFPu)5Nagy/J mice (Jackson Laboratory) as described
previously. Briefly, bone marrow cells were enriched for lineage
negative (Lin2) cells using the SpinSep system (Stem Cell
Technologies) and plated on tissue culture treated plates at a
density of 0.16106 cells/cm2 in murine Mesencult media (basal
media + stimulatory supplement; Stem Cell Technologies) with
100 units/ml penicillin, 100 mg/ml streptomycin and 0.25 mg/ml
amphotericin B added. MSC from passage 15–20 were used in
these studies which were found to be Sca-1+, CD34+, CD45low,
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CD90.12, CD1052, and cKit2 as determined by flow cytometry
[1].
MSC-conditioned media (CM) was prepared by plating
2.06106 MSC in 10 ml Mesencult on 100 mm tissue culture
treated plates for 48 hours. Following culture, the media was
filtered through a 0.22 mm membrane.
Analysis of MSC for Growth Factors and Cytokines
In order to determine whether MSC secrete paracrine factors,
Mesencult and CM were analyzed for the presence of various
growth factors and cytokines using multiplex assay kits and
Luminex technology (BioSource/Invitrogen). A custom mouse 10-
plex kit was designed to test for vascular endothelial growth factor
(VEGF), monocyte chemoattractant protein-1 (MCP-1), interfer-
on-c (IFN-c), monokine induced by IFN-c (MIG), macrophage
inflammatory protein-1a (MIP-1a), MIP-1b, MIP-3b, tumor
necrosis factor-a (TNF-a), fibroblast growth factor-basic (FGF-
basic), and regulated upon activation normal T-cell expressed and
secreted (RANTES). A mouse single-plex kit was used for platelet
derived growth factor-BB (PDGF-BB). All procedures were carried
out according to the manufacturer’s instructions. Briefly, 50 ml of
media was added to wells containing antibody coated beads and
incubated 2 hours at room temperature. The beads were washed,
treated with biotinylated detector antibody for 1 hour, washed,
and incubated with streptavidin-RPE for 30 minutes. Following
washing, fluorescence was detected using a Luminex-100 instru-
ment and analyzed with proprietary software.
In order to determine whether MSC synthesized the paracrine
factors identified in CM, RNA was isolated directly from MSC
cultures grown two days in Mesencult in 6-well plates using an
RNA4PCR kit including DNAse treatment (Ambion). Reverse
transcription of 1 mg RNA was performed using an iScript cDNA
Synthesis Kit with blended oligo(dT) and random hexamer
primers (BioRad). PCR was done using iTaq DNA polymerase
(BioRad), 1.5 mM MgCl2, 200 mM dNTP, 2 ml RT reaction
product and 300 mM primers (Table 1). After an initial 95uC hot
start, 30–50 cycles of 95uC (30 seconds), 55uC (30 seconds) and
72uC (1 minute) was performed.
Angiogenesis Assay
The effect of paracrine factors secreted by MSC into CM on
angiogenesis was studied using canine jugular vein vascular
endothelial cells (CVEC; AllCells) and the Fibrin Gel In Vitro
Angiogenesis Assay Kit (Chemicon #ECM630). CVEC were
initially cultured on gelatin-coated plates in CVEC basal medium
plus stimulatory supplements (AllCells). Adherent cells were
removed with trypsin and placed in culture wells coated with a
fibrin matrix as described by the manufacturer (Chemicon).
50,000 CVEC/well in 24-well plates or 5,000 cells/well in 96 well
plates were plated on the fibrin matrix in one of three types of
media (n = 19): 1) Mesencult (negative control), 2) Mesencult
+10 mg/ml insulin, 5.5 mg/ml transferrin, 5 ng/ml sodium
selenite (positive control) or 3) conditioned media (CM). The cells
were covered 24 hours later with a second layer of fibrin, fresh
media was applied, and the cells were cultured for an additional 4
days. Cultures were analyzed for the presence of endothelial
capillary tube cellular networks using a semiquantitative scale (0–4)
where 0 = cultures with no cellular organization and 4= cultures
where cells showed complete organization with polygonal
structure.
Cell Migration Assay
The effect of VEGF, MCP-1 and MIP-1a on MSC migration
was studied by seeding 600,000 cells in 500 ml Mesencult onto
10 mm diameter tissue culture inserts with a 3.0 mM pore
polycarbonate membrane (Nunc). The inserts were placed in 24-
well culture plates containing 600 ml/well Mesencult with or
without 30 ng/ml VEGF, 30 ng/ml MCP-1 or 100 pg/ml MIP-
1a. After 6 hours at 37uC, the membranes were stained for 5 min
in 30 mM acridine orange, washed in PBS, cut out, and mounted
on slides in PBS with a coverslip. The underside of the membrane
was viewed on a fluorescence microscope (490 nm excitation/
520 nm emission), and the number of yellow-green fluorescing
nuclei counted using the 206 objective. A mean of ten random
visual fields was measured per membrane and each membrane
was considered one trial. Data were expressed as a percent of
control and analyzed using Student’s t-test with p,0.05
considered statistically significant (n = 6).
Caspase-3 Assay
The effect of paracrine factors secreted by MSC on caspase-3
was studied by treating rat embryonic cardiac myoblast H9c2 cells
(ATCC #CRL-1446) with CM. 1.56106 H9c2 cells in 10 ml
DMEM +10% FBS were plated on 100 mm tissue culture treated
plates. After 24 hours the media was changed to DMEM +1%
heat inactivated horse serum and the cells were cultured for an
additional 48 hours. The media was replaced with Mesencult
(control) or CM and the cultures were incubated under hypoxic
conditions (1% O2, 5% CO2, 94% N2) for up to 24 hours. In some
cases, either 1 mM phosphatidylinositol 3-kinase c (PI 3-Kc)
inhibitor (Calbiochem #528106) in DMSO or 4 nM mouse
recombinant MCP-1 (GenWay #10-783-79110) were added to
the cultures. Equal amounts (1%) of DMSO (vehicle) were added
to control cultures when the PI 3-Kc inhibitor was used.
Caspase-3 activity in cell lysates was determined using an
enzymatic assay. H9c2 cells treated with Mesencult, CM, MCP-1
or PI 3-Kc inhibitor for 24 hours were lifted with trypsin
(including all cells floating in media and washes) and 1–26106
cells were analyzed for caspase-3 activity using the ApoAlert
Caspase-3 Colorimetric Assay Kit (Clontech #630216). For each
experimental run, the cell number for each treatment group was
equalized. Cells were lysed by incubating on ice for 10 minutes
with ice cold lysis buffer. Cells were centrifuged at 14,0006g for
5 min. and the supernatant was assayed according to the
manufacturer’s directions. Caspase-3 activity was expressed as a
percent of control activity and analyzed using Student’s t-test.
ELISA Assay
An ELISA was used to detect changes in the levels of total-Bad,
phospho-Bad (Ser112), total-Akt, phospho-Akt (Ser473), phospho-
Akt (Thr308) and ERK 1/2 using PathScan Sandwich ELISA Kits
(Cell Signaling Technology #7162, 7182, 7170, 7160, 7252) or a
STAR ERK 1/2 ELISA kit (Upstate #17-463). H9c2 cultures
were treated with Mesencult, CM, MCP-1, 1 mM PI 3-Kc
Table 1. PCR Primers.
Forward Reverse
VEGF CAGGCTGCTGTAACGATGAA TGTCTTTCTTTGGTCTGCATTC
MCP-1 AGGTCCCTGTCATGCTTCTG TCTGGACCCATTCCTTCTTG
MIG TCTTTTCCTCTTGGGCATCATCTT TTTCCCCCTCTTTTGCTTTTTCTT
MIP-1a TGCCCTTGCTGTTCTTCTCT CCCAGGTCTCTTTGGAGTCA
MIP-1b TGTCTGCCCTCTCTCTCCTC GTCTGCCTCTTTTGGTCAGG
doi:10.1371/journal.pone.0035685.t001
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inhibitor or 30 mM ERK 1/2 inhibitor (ERK inhibitor II;
Calbiochem) for 6 or 24 hours and analyzed. Cell lysates were
prepared by incubating H9c2 cultures (100 mm plates) on ice for
10 minutes with 500 ml ice cold lysis buffer (Cell Signaling
Technology #9803)+1 mM PMSF. Cells were scraped, sonicated,
centrifuged at 14,0006g for 5 min., and the supernatant stored at
280uC. Lysates were tested according to the manufacturer’s
instructions and analyzed with a plate reader at 450 nm. Protein
concentration in cell lysates was determined using a BCA protein
assay kit (Pierce). Levels were calculated per mg protein, expressed
as a percent of the relevant control, and analyzed using Student’s
t-test.
Results
Growth Factors and Cytokines in MSC-Conditioned
Media (CM)
Levels of growth factors and cytokines were measured in
Mesencult (control) media (n = 3) and CM (n=5) using Luminex
technology. VEGF, MCP-1, MIG, MIP-1a and MIP-1b were
absent in control media and found to be elevated in CM (Table 2).
RNA transcripts for these five growth factors and cytokines were
detected in MSC using RT-PCR (Figure 1). MIP-3b, IFN-c, TNF-
a, and PDGF-BB were absent in both types of media while FGF-
basic and RANTES were present in very low concentrations in
both control media and CM (data not shown).
Effect of MSC-Conditioned Media on Angiogenesis in
CVEC
To determine whether the paracrine factors released by MSC
promote angiogenesis, canine vascular endothelial cells (CVEC)
were cultured on a fibrin matrix in the presence or absence of CM
(Figure 2). In every case (n = 19), CVEC cultures treated with CM
(Figure 2C) developed complex capillary networks (semiquantita-
tive scores of 2–3) similar to those observed in the positive control
cultures containing insulin, transferrin and sodium selenite
(Figure 2B; scores = 3–4). These networks were absent in control
cultures (Figure 2A; scores = 0–1).
Effect of Cytokines on MSC Migration
The cytokines secreted by MSC were tested for their ability to
affect the migration of MSC through a 3.0 mM polycarbonate
membrane (n= 6). Cells were counted when the nuclei were
observed on the underside of the membrane (Figure 3A). As shown
in Figure 3B, 30 ng/ml VEGF treatment resulted in a decrease in
MSC migration (63.8610.9% of control) while 30 ng/ml MCP-1
and 100 pg/ml MIP-1a increased migration to 257.1643.7% and
157.6623.2% of control, respectively (p,0.05). Since the VEGF
mediated reduction in MSC migration was surprising, we tested
3 ng/ml VEGF and found that this concentration also reduced
migration (50.167.2% of controls, p,0.01).
Effect of MSC-Conditioned Media on Caspase-3 and Akt/
Bad Phosphorylation in H9c2 Cells
Rat neonatal H9c2 myoblasts were used to test the hypothesis
that paracrine factors secreted by MSC inhibit caspase-3, a later
marker of apoptosis. H9c2 cells were cultured in the presence or
absence of CM while under hypoxic conditions for 24 hours to
induce apoptosis and then tested for caspase-3 activity (n = 6). As
shown in Figure 4, CM was able to significantly (p,0.05) reduce
caspase-3 activity to 84.565.5% of control levels.
Since Akt [3] and Bad [4] are involved in the apoptotic
pathway, the phosphorylation state of these proteins in H9c2 cells
was monitored using ELISA (Figure 4. Phospho-Akt (Ser473) and
phospho-Bad (Ser112) were significantly reduced by CM after
24 hours to 79.066.4% and 60.667.9% of control values
(p,0.05; n = 6), respectively. In contrast, CM significantly
increased phospho-Akt (Thr308) to 147.5615.3% of control
values (p,0.01; n = 12) in H9c2 cells. No changes in total Akt
or Bad were observed (data not shown).
Effect of MCP-1 and PI 3-Kc inhibitor on Caspase-3 and
Akt/Bad Phosphorylation in H9c2 Cells
Since MCP-1 is a major paracrine factor secreted by MSC, we
wanted to determine whether changes observed after CM
treatment were due to this cytokine. Therefore, H9c2 cells were
cultured under hypoxic conditions for 24 hours in either
Mesencult (control) or Mesencult containing 4 ng/ml MCP-1
with or without 1 mM phosphoinositol-3-kinase-gamma (PI 3-Kc)
inhibitor for 24 hours (n = 6). PI 3-Kc is activated by MCP-1
during induction of chemotaxis [5]. A concentration range of
0.001–1.0 mM PI 3Kc had no effect on caspase-3 activity in
control cultures while 20 and 200 mM completely suppressed this
activity (data not shown).
The addition of MCP-1 resulted in a significant decrease
(p,0.01) in caspase-3 activity to 87.762.4% similar to that found
for CM; however, the PI 3-Kc inhibitor did not reverse the effect
of MCP-1 on caspase-3 (Figure 5). Interestingly, when PI 3-Kc
inhibitor was added to CM, it was able to reverse the effect of CM
on caspase-3 while having no effect on control cultures (Figure 6).
MCP-1 treatment significantly reduced (p,0.01) phospho-Akt
(Ser473) compared to Mesencult controls (81.462.5% of control),
while the inclusion of the PI 3-Kc inhibitor with MCP-1 did not
alter its effect (Figure 5). MCP-1 and MCP-1 + PI 3-Kc inhibitor
had no significant effect on phospho-Akt (Thr308) or phospho-Bad
(Ser112) compared to Mesencult controls (Figure 5). Total Akt and
Bad were unaffected by the treatments as well (data not shown).
The decline in phospho-Akt (Ser473) caused by MCP-1 was
similar to that found for CM; however, changes in phospho-Akt
(Thr308) and phospho-Bad (Ser112) induced by CM did not occur
in response to MCP-1 (compare Figures 4 and 5).
Figure 1. PCR products from RT reactions on RNA isolated from
MSC. From left to right: VEGF, MCP-1, MIG, MIP-1a, MIP-1b.
doi:10.1371/journal.pone.0035685.g001
Table 2. Cytokines in MSC-Conditioned Media.
VEGF MCP-1 MIG MIP-1a MIP-1b
Mes (n=3) ND ND ND ND ND
CM (n=5) 42796187 39016255 11.4860.79 9.4163.88 57.3763.72
Data reported as mean 6 SE in pg/ml. Mes =Mesencult, CM=MSC-conditioned
media, ND=non-detectable.
doi:10.1371/journal.pone.0035685.t002
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Role of ERK during the Effect of Conditioned Media on
Intracellular Signaling in H9c2 Cells
Since phosphorylated ERK is an important kinase activated
during receptor mediated intracellular signaling, we wanted to test
the role that ERK might play in the changes occurring in H9c2
cells after CM treatment. Therefore, phospho-ERK 1/2 was
monitored by ELISA in H9c2 cells after 6 and 24 hours of
treatment with Mesencult or CM under hypoxic conditions (n = 6).
As seen in Figure 7, CM significantly reduced the levels of
phospho-ERK 1/2 after 6 hours to 61.469.9% of control
(p,0.05). There was no difference between control and CM
treated cells after 24 hours (32.561.7% and 30.863.5% of the
6 hour control), but the levels of both were significantly lower after
24 hours compared to the 6 hour control (p,0.01).
Since phospho-ERK 1/2 levels were significantly lower in CM
treated cells after 6 hours, we wanted to determine whether this
loss of ERK 1/2 activation was responsible for the changes seen in
phospho-Akt and phospho-Bad. H9c2 cells were treated with
Mesencult, CM, or 30 mM ERK 1/2 inhibitor under hypoxic
conditions for 6 hours (n = 6). As shown in Figure 8, CM
significantly reduced phospho-Akt (Ser473) to 68.466.9% and
phospho-Bad (Ser112) to 44.869.7% of control values (p,0.05
and 0.01, respectively). ERK 1/2 inhibition resulted in a similar
significant reduction of phospho-Akt (Ser473) and phospho-Bad
(Ser112) after 6 hours to 35.661.9% (p,0.01) and 65.167.7%
(p,0.05) compared to controls. Phospho-Akt (Thr308) levels were
maintained in CM treated cells after 6 hours (91.265.1; n= 6);
however, ERK 1/2 inhibition resulted in a significant decline in
phospho-Akt (Thr308) levels to 46.962.0% (p,0.01; n= 6).
Comparing the changes at 6 hours (Figure 8) with those at
24 hours (Figure 4), CM caused a similar decline in phospho-Akt
(Ser473) and phospho-Bad (Ser112) at both time points. However,
the increase in phospho-Akt (Thr308) seen at 24 hours was not yet
present at 6 hours.
Discussion
Our study clearly identifies specific bone marrow-derived MSC
secreted paracrine factors that are able to induce angiogenesis,
affect cellular migration and attenuate caspase-3. This supports
our previous in vivo study [1] where we concluded that the
cardioprotective effect of intravenous administration of MSC after
myocardial infarction was likely due to paracrine secretions from
the MSC, a mechanism supported by other investigators [6–8].
Unique to our study, we quantified secretion of VEGF, MCP-1,
MIG, MIP-1a, and MIP-1b by MSC into the surrounding media,
and were able to detect mRNA in MSC for the same factors. Basic
FGF, MIP-3b, RANTES, INF-c, TNF-a, and PDGF were also
measured but were not elevated compared to control levels. Singla
and McDonald [9] found that human embryonic stem cells
Figure 2. Effect of MSC-conditioned media on angiogenesis. Canine vascular endothelial cells plated on a fibrin matrix exposed to treatment
media for 5 days. A: Cells treated with Mesencult. B: Cells treated with Mesencult containing insulin, transferrin and sodium selenite. C: Cells treated
with conditioned media.
doi:10.1371/journal.pone.0035685.g002
Figure 3. Effect of cytokines on MSC migration. A: Cells stained with acridine orange on the underside of the 3 mm polycarbonate membrane
after MIP-1a treatment. Yellow-green=DNA; red = RNA. B: Effect of VEGF, MCP-1 and MIP-1a on MSC migration. Data expressed as a mean percent of
Mesencult (control) treated cultures 6 SE (n = 6). a = p,0.05 compared to controls.
doi:10.1371/journal.pone.0035685.g003
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released paracrine factors that reduced apoptosis in H9c2 cells and
focused on TIMP-1 (tissue inhibitor of metalloproteinase) as an
important molecule in this process. Other investigators have
identified a number of factors secreted by cord blood derived [10]
and embryonic stem cell derived [11] MSC including VEGF and
MCP-1 but did not determine their specific biologic effects.
We were able to demonstrate significant biologic activity for the
factors secreted by MSC. MSC-conditioned media promoted
angiogenesis by CVEC, and the conditioned media components
VEGF and MCP-1 have established angiogenic properties [12–
14]. We demonstrated that both MCP-1 and MIP-1a were able to
promote cellular migration of MSC while VEGF inhibited MSC
migration. Other investigators have shown that all three factors
promote MSC migration[15–19], although a few reports were
unable to demonstrate an effect of MCP-1 and VEGF[20,21]. Our
result showing a decline in MSC migration after VEGF might be
explained by differences in culture conditions, the most notable
being our high serum concentration (20% FBS in Mesencult vs.
1% or less in most studies). MSC-conditioned media reduced
caspase-3 activity in H9c2 cells, and MCP-1 was able to mimic this
pro-survival effect. In addition to promoting monocyte chemotax-
is, MCP-1 has been shown to be both pro- and anti-apoptotic in
cardiomyocytes [22,23]. The G-protein coupled receptor for
MCP-1, CCR2, can act through Gai, Gas or Gaq depending on
the cell type [24]. Interestingly, Tarzami and coworkers [23]
found that while the stimulation of chemotaxis by MCP-1 in
monocytes was dependent upon the activation of Gai and Gas, the
pro-survival effect of MCP-1 in cardiomyocytes acted independent
of these, most likely through the Gaq pathway.
The chemoattractant properties of MCP-1 are mediated
through the gamma isoform of PI-3 kinase [5]. However, the
reduction in caspase-3 activity by MCP-1 in our study was
Figure 4. Effect of MSC-conditioned media on caspase-3, Akt and Bad. Changes in caspase-3, phospho-Akt (Ser473), phospho-Akt (Thr308)
and phospho-Bad (Ser112) in H9c2 cells treated with Mesencult (Mes) or conditioned media (CM) for 24 hours under hypoxic conditions. Data
calculated as a mean percent of Mesencult (control) treated cultures 6 SE. a = p,0.05, b =p,0.01 compared to controls.
doi:10.1371/journal.pone.0035685.g004
Figure 5. Effect of MCP-1 and PI 3-Kc inhibitor on caspase-3, Akt and Bad. Changes in caspase-3, phospho-Akt (Ser473), phospho-Akt
(Thr308) and phospho-Bad (Ser112) in H9c2 cells treated with Mesencult (Mes), MCP-1 or MCP-1 + PI 3-Kc inhibitor for 24 hours under hypoxic
conditions. Data calculated as a percent of Mesencult (control) treated cultures 6 SE. a = p,0.05, b =p,0.01 compared to controls.
doi:10.1371/journal.pone.0035685.g005
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mediated by an intracellular signaling pathway independent of PI-
3 kinase c since the addition of a specific inhibitor of this enzyme
along with MCP-1 did not reduce the protective effect of this
chemokine. Interestingly, the addition of the PI-3 kinase c
inhibitor to MSC-conditioned media did prevent its protective
effect suggesting that conditioned media contains other pro-
survival factors in addition to MCP-1 which may act through PI-3
kinase c-dependent pathways. These findings are consistent with
Singla and coworkers [25] who reported that the PI-3 kinase
inhibitor, LY-294002 was able to abolish the protective effect of
embryonic stem cell conditioned media in H9c2 cells, although it
was not reported whether MCP-1 was elevated in their
conditioned media, and LY-294002 is not specific to the gamma
isoform of PI-3 kinase. Taken together, these data suggest that
multiple paracrine factors in conditioned media, possibly from
different cell types within the stem cell population, are responsible
for the pro-survival response and exert their effects through both
PI-3 kinase dependent and independent pathways.
We found that phospho-Akt (Ser473) was lower in MSC-
conditioned media treated cells while phospho-Akt (Thr308) was
elevated. MCP-1 also reduced phospho-Akt (Ser473) but had no
effect on Thr308; PI-3 kinase c inhibition concurrent with MCP-1
yielded similar results. These findings suggest that 1) phosphor-
ylation of Akt at Thr308 might be responsible for the pro-survival
effect of conditioned media and 2) in addition to its PI-3 kinase
independent effect on caspase-3 activity, the protective effect of
MCP-1 is not mediated by Akt activation. Activation of PI-3
kinase results in the activation of PDK1 which phosphorylates Akt
at the Thr308 site while the process responsible for phosphory-
lation of the Ser473 site is less clear and may involve mTOR,
autophosphorylation, or other mechanisms [26]. Akt is known to
be part of a pro-survival pathway; phosphorylation at Thr308 is
required for Akt activation and increases its catalytic activity 100
fold while phosphorylation at Ser473 is dependent on phosphor-
ylation at Thr308 and potentiates its activation approximately 10
fold [3].
Since multiple signaling pathways are involved, we also studied
ERK 1/2 and found that phospho-ERK 1/2 was reduced in H9c2
cells following 6 hour treatment with CM, suggesting that
inhibition of ERK was part of the overall response of these cells
to CM. Phosphorylation of ERK 1/2 is involved in doxorubicin-
mediated cell death in H9c2 cells [27], and oxidative stress in these
cells promotes both cell death and ERK activation [28]. Whether
ERK is involved in proliferation or cell death depends on the cell
type and signaling molecules present [29]. Our results also show
that direct ERK 1/2 inhibition reduced phosphorylation at both
Ser473 and Thr308 suggesting that ERK regulation after CM
treatment may be involved in the reduction of Ser473 but not the
increase in Thr308. Interestingly, MSC-conditioned media
maintained phosphorylation at Thr308 after 6 hours and
increased it after 24 hours. Thus, although ERK 1/2 signaling is
reduced by conditioned media, some other factor in the media
counteracts the effect of ERK inhibition on Thr308 phosphory-
lation causing it to rise.
Another potential target in the apoptotic signaling pathway that
we explored was Bad phosphorylation. Bad is also anti-apoptotic
when phosphorylated [3,4] but its control pathway is very
complex. Bad is pro-apoptotic and binds via its BH3 domain to
anti-apoptotic Bcl-2/Bcl-XL, inhibiting its function. Bad can be
Figure 6. Effect of MSC-conditioned media and PI 3-Kc inhibitor on caspase-3 activity. H9c2 cells treated for 24 hours under hypoxic
conditions. Data calculated as a percent of Mesencult (control) treated cultures 6 SE. a = p,0.05 compared to controls.
doi:10.1371/journal.pone.0035685.g006
Figure 7. Effect of MSC-conditioned media on phospho-ERK 1/
2. H9c2 cells treated for 6 or 24 hours under hypoxic conditions. Data
calculated as a percent of the 6-hr Mesencult (control) treated cultures
6 SE. a =p,0.05, b = p,0.01 compared to controls.
doi:10.1371/journal.pone.0035685.g007
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phosphorylated at a number of serine sites (Ser112, 128, 136, 155,
170), preventing it from binding to Bcl-2/Bcl-XL and inhibiting
this anti-apoptotic pathway [30–34]. Bad is phosphorylated via a
number of signaling systems; for example, PKA [35], RSK1 [33]
and ERK (MAPK) [30] can phosphorylate Bad at Ser112, Akt
(PKB) phosphorylates Bad at Ser136 [31], and PKA, RSK1 and
survival factor are involved in phosphorylation at Ser155.
Phosphorylation at any of these sites promotes its binding and
subsequent sequestration by 14-3-3 proteins preventing binding to
Bcl-2/Bcl-XL. Dephosphorylation at both Ser112 and Ser136 is
required for release from 14-3-3 [30,31]. We found that both
MSC conditioned media and ERK 1/2 inhibition reduced
phospho-Bad (Ser112) while MCP-1 alone had no effect. As
discussed above, other factors are most likely present in the MSC-
conditioned media that control apoptosis and these might act
through phosphorylation of Akt at Thr308. It is not immediately
clear why Akt (Ser473) and Bad (Ser112) were reduced, since this
would tend to promote and not inhibit apoptosis; however, other
Bad phosphorylation sites or downstream effectors may be
involved in the pro-survival effect of MSC-conditioned media.
In summary, bone marrow MSC secretes factors that act in a
paracrine manner to promote angiogenesis, alter cell migration
and inhibit apoptosis. Both MCP-1 and MIP-1a were able to
promote cellular migration of MSC and MCP-1 displayed a
protective effect by reducing caspase-3 activity in H9c2 cells. The
overall protective effect of CM was demonstrated to include PI 3-
kinase and the phosphorlylation of Akt (Thr308), but the MCP-1
effect was independent of PI 3-kinase and Thr308 phosphoryla-
tion. CM also caused a reduction in ERK 1/2 activity that was
unrelated to the increase in Thr308 phosphorylation. It is likely
that multiple pro-survival factors in addition to MCP-1 are
secreted by MSC which act on several pathways. Further study
will help delineate the specific pathways used by MCP-1 and the
other identified factors and whether they contribute to the
beneficial effects of stem cell therapy following tissue damage
after myocardial infarction.
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